Prostate Cancer Trial, Recruiting NCT07231159 Sponsor: AdventHealth Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT07231159
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People seeking care at a participating clinic or emergency department
  • People who meet the screening criteria for at least one of the following cancers: lung cancer (adults aged 50 to 80 who have smoked at least 20 pack-years and currently smoke or quit within the last 15 years), breast cancer (women aged 40 to 74), or prostate cancer (men aged 55 to 69)
  • People who receive a positive screening result for lung, breast, and/or prostate cancer at a study site

Who may not be able to join:

  • People whose behaviour is considered disruptive to other patients or staff
  • People who decline cancer screening for breast, lung, and/or prostate cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mark Socinski, MD, AdventHealth

Phone: 407-303-3286

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
AdventHealth
Registry
ClinicalTrials.gov
Start date
17 November 2025
Est. completion
30 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The categorization of the RE-AIM model dimensions of Reach, Effectiveness, Adoption, Implementation, and Maintenance,

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov